Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
RTOG-9914: Cisplatin and Boost Radiation for Head and Neck Cancer
NCT00005088Phase 2Completed
- Sponsor
- NRG Oncology
- Start
- Apr 2000
- Primary completion
- Jan 2002
- Modality
- Small Molecules
- Countries
- 2
01
Overview
Phase 2, open-label, single-arm trial of cisplatin in head and neck squamous cell carcinoma (HNSCC), sponsored by NRG Oncology. Primary endpoint: Rate of Local Regional Recurrence at 1 year. Started Apr 2000; status: completed.
02
Drugs
cisplatin
03
Conditions
head and neck squamous cell carcinoma (HNSCC)
Beyond the preview
Go deeper on NCT00005088.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00005088.